share_log

Perficient Analyst Ratings

Perficient Analyst Ratings

熟練的分析師評級
Benzinga ·  2023/10/31 16:45
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
10/31/2023 25.45% Needham $85 → $73 Maintains Buy
07/31/2023 20.3% Scotiabank $80 → $70 Downgrades Sector Outperform → Sector Perform
07/28/2023 Scotiabank Downgrades Sector Outperform → Sector Perform
07/28/2023 32.33% Barrington Research $85 → $77 Maintains Outperform
07/28/2023 20.3% JP Morgan $84 → $70 Downgrades Overweight → Neutral
07/28/2023 46.07% Needham → $85 Reiterates Buy → Buy
05/19/2023 46.07% Barrington Research → $85 Reiterates Outperform → Outperform
05/03/2023 28.89% Morgan Stanley $70 → $75 Maintains Equal-Weight
05/03/2023 46.07% Needham → $85 Reiterates → Buy
04/17/2023 46.07% Barrington Research → $85 Reiterates → Outperform
03/01/2023 46.07% Needham $95 → $85 Maintains Buy
02/17/2023 National Alliance Securities Downgrades Buy → Neutral
01/27/2023 20.3% Morgan Stanley $75 → $70 Maintains Equal-Weight
10/28/2022 28.89% Morgan Stanley $100 → $75 Maintains Equal-Weight
10/28/2022 37.48% Barrington Research $110 → $80 Maintains Outperform
10/27/2022 63.26% Needham $120 → $95 Maintains Buy
09/27/2022 46.07% Alliance Global Partners $100 → $85 Upgrades Neutral → Buy
09/14/2022 58.1% Jefferies $131 → $92 Maintains Buy
08/08/2022 71.85% Morgan Stanley $120 → $100 Maintains Equal-Weight
08/05/2022 106.22% Needham $145 → $120 Maintains Buy
07/20/2022 111.38% JP Morgan $133 → $123 Maintains Overweight
06/30/2022 89.04% Scotiabank → $110 Initiates Coverage On → Sector Outperform
04/26/2022 106.22% Morgan Stanley → $120 Initiates Coverage On → Equal-Weight
02/25/2022 149.18% Needham $155 → $145 Maintains Buy
10/18/2021 166.37% Needham $130 → $155 Maintains Buy
10/15/2021 114.81% Alliance Global Partners $104 → $125 Downgrades Buy → Neutral
08/27/2021 123.41% Needham $110 → $130 Maintains Buy
08/17/2021 116.53% JP Morgan $100 → $126 Upgrades Neutral → Overweight
07/30/2021 97.63% Maxim Group $83 → $115 Maintains Buy
07/30/2021 99.35% Barrington Research $75 → $116 Maintains Outperform
03/30/2021 16.86% JP Morgan → $68 Initiates Coverage On → Neutral
10/30/2020 -20.95% Needham $45 → $46 Maintains Buy
06/19/2020 -29.54% Needham $40 → $41 Maintains Buy
05/08/2020 -31.26% Needham $37 → $40 Maintains Buy
03/20/2020 -36.42% Needham $51 → $37 Maintains Buy
10/22/2019 -20.95% National Securities Corporation → $46 Initiates Coverage On → Buy
09/09/2019 William Blair Initiates Coverage On → Outperform
06/21/2019 -31.26% Nomura → $40 Initiates Coverage On → Buy
11/20/2018 -48.44% Jefferies → $30 Initiates Coverage On → Buy
日期 上行/下行 分析公司 目標價格變化 評級變化 上一次/當前評級
2023年10月31日 25.45% 李約瑟 $85→$73 維護
07/31/2023 20.3% 加拿大豐業銀行 $80→$70 評級下調 行業表現優於→行業表現
07/28/2023 - 加拿大豐業銀行 評級下調 行業表現優於→行業表現
07/28/2023 32.33% 巴靈頓研究公司 $85→$77 維護 跑贏大盤
07/28/2023 20.3% 摩根大通 $84→$70 評級下調 超重→中性
07/28/2023 46.07% 李約瑟 →$85 重申 購買→購買
2023年05月19日 46.07% 巴靈頓研究公司 →$85 重申 跑贏→跑贏大盤
05/03/2023 28.89% 摩根士丹利 $70→$75 維護 等重
05/03/2023 46.07% 李約瑟 →$85 重申 →購買
04/17/2023 46.07% 巴靈頓研究公司 →$85 重申 →跑贏大盤
03/01/2023 46.07% 李約瑟 $95→$85 維護
02/17/2023 - 國聯證券 評級下調 購買→中性
2023年1月27日 20.3% 摩根士丹利 $75→$70 維護 等重
10/28/2022 28.89% 摩根士丹利 $100→$75 維護 等重
10/28/2022 37.48% 巴靈頓研究公司 $110→$80 維護 跑贏大盤
10/27/2022 63.26% 李約瑟 $120→$95 維護
09/27/2022 46.07% 聯盟全球合作夥伴 $100→$85 升級 中性→購買
09/14/2022 58.1% 傑富瑞 $131→$92 維護
2022/08/08 71.85% 摩根士丹利 $120→$100 維護 等重
08/05/2022 106.22% 李約瑟 $145→$120 維護
07/20/2022 111.38% 摩根大通 $133→$123 維護 超重
2022/06/30 89.04% 加拿大豐業銀行 →$110 開始承保 →板塊跑贏大盤
04/26/2022 106.22% 摩根士丹利 →$120 開始承保 →等重
02/25/2022 149.18% 李約瑟 $155→$145 維護
10/18/2021 166.37% 李約瑟 $130→$155 維護
2021年10月15日 114.81% 聯盟全球合作夥伴 $104→$125 評級下調 購買→中性
2021/08/27 123.41% 李約瑟 $110→$130 維護
2021/08/17 116.53% 摩根大通 $100→$126 升級 中性→超重
07/30/2021 97.63% Maxim集團 $83→$115 維護
07/30/2021 99.35% 巴靈頓研究公司 $75→$116 維護 跑贏大盤
03/30/2021 16.86% 摩根大通 →$68 開始承保 →中性
10/30/2020 -20.95% 李約瑟 $45→$46 維護
2020/06/19 -29.54% 李約瑟 $40→$41 維護
05/08/2020 -31.26% 李約瑟 $37→$40 維護
03/20/2020 -36.42% 李約瑟 $51→$37 維護
2019年10月22日 -20.95% 國家證券公司 →$46 開始承保 →購買
2019年09月09日 - 威廉·布萊爾 開始承保 →跑贏大盤
2019年06月21日 -31.26% 野村 →$40 開始承保 →購買
2018年11月20日 -48.44% 傑富瑞 →$30 開始承保 →購買

What is the target price for Perficient (PRFT)?

Perficient(PRFT)的目標價是多少?

The latest price target for Perficient (NASDAQ: PRFT) was reported by Needham on October 31, 2023. The analyst firm set a price target for $73.00 expecting PRFT to rise to within 12 months (a possible 25.45% upside). 13 analyst firms have reported ratings in the last year.

李約瑟於2023年10月31日報道了Perfent(納斯達克:PRFT)的最新目標價。這家分析公司將目標價定為73.00美元,預計PRFT將在12個月內上漲(可能上漲25.45%)。過去一年,有13家分析公司公佈了評級。

What is the most recent analyst rating for Perficient (PRFT)?

普惠金融(PRFT)最新的分析師評級是多少?

The latest analyst rating for Perficient (NASDAQ: PRFT) was provided by Needham, and Perficient maintained their buy rating.

納斯達克(Sequoia Capital:PRFT)的最新分析師評級由Needham提供,Perfient維持其買入評級。

When is the next analyst rating going to be posted or updated for Perficient (PRFT)?

下一次發佈或更新Perficient(PRFT)分析師評級的時間是什麼時候?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Perficient, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Perficient was filed on October 31, 2023 so you should expect the next rating to be made available sometime around October 31, 2024.

分析師在進行了廣泛的研究後得出了股票評級,其中包括查閱公共財務報表,與Perficient的高管和客戶交談,以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次,所以你每年應該會得到每家公司每家公司的4個評級。對Perficient的上一次評級是在2023年10月31日提交的,因此您應該預計下一次評級將在2024年10月31日左右提供。

Is the Analyst Rating Perficient (PRFT) correct?

分析師評級合格(PRFT)正確嗎?

While ratings are subjective and will change, the latest Perficient (PRFT) rating was a maintained with a price target of $85.00 to $73.00. The current price Perficient (PRFT) is trading at is $58.19, which is out of the analyst's predicted range.

雖然評級是主觀的,並將發生變化,但最新的合格(PRFT)評級維持不變,目標價在85.00美元至73.00美元之間。普惠目前的股價為58.19美元,超出了分析師的預測區間。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論